Robert A. Berman

Chief Executive OfficeratenVVeno Medical· In proxies 2022–2025

Pay in FY2024-38% from the year before · enVVeno Medical stock -41.2% the same year

Robert A. Berman was paid $1.2M in FY2024 (Dec), down 38%. enVVeno Medical stock fell 41.2% that year.

Pay$100 in the stock at the end of FY21 → $46

Pay is from the Summary Compensation Table of each enVVeno Medical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NVNO
enVVeno MedicalPublic company · 4 yr
- Chief Executive Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

Pay
enVVeno Medical CEO pay fell 38% to $1.2M. The stock fell 41% in FY2024 (Dec).
DEF 14AOct 30, 2025
Pay
enVVeno Medical CEO pay rose 301% to $1.9M. The stock rose 1% in FY2023 (Dec).
DEF 14ANov 19, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?